DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) share price today?

GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) is trading at ₹143.78 on the NSE, up 4.99% on the day. Source: DocStoX.

What is the PE ratio of GAUDIUM IVF N WOMEN H L?

GAUDIUM IVF N WOMEN H L has a price-to-earnings (PE) ratio of 42.8 in the Healthcare sector.

What is the market capitalisation of GAUDIUM IVF N WOMEN H L?

GAUDIUM IVF N WOMEN H L has a market capitalisation of approximately ₹1,034 crore.

GAUDIUM IVF N WOMEN H L

GAUDIUMIVF·NSE·Healthcare

₹143.78▲ +6.84 (+4.99%)

Healthcare · Healthcare Service Provider

Revenue compounding 33% a year

Day₹137.55

₹143.78

52W₹69

₹144100%

Open

₹139.00

High

₹143.78

Low

₹137.55

Prev Close

₹136.94

Volume

4.11L

VWAP

₹143.40

Snapshot

Key fundamentals

Market Cap

₹1,034 Cr

P/E Ratio

42.79Expensive

P/B Ratio

5.62

EPS

₹3.36

Book Value

₹20.90

ROE

24.70%Strong

ROCE

29.00%Efficient

Dividend Yield

0.00%

Debt / Equity

0.16Low

Face Value

₹5.00

52W High

₹143.78

52W Low

₹69.18

Sector

Healthcare

Industry

Healthcare Service Provider

Avoid

Narrow moatMedium uncertainty

Fair value estimate

₹38

▼ 73.8%downside

Trading at ₹144 — 74% above our estimate

BearFair valueBull

₹32₹38₹43

/100

Business quality — Solid

Growth 89Profitability 99Efficiency 50Valuation 55

Plain English

Our view

Revenue compounding 33% a year
Low debt relative to equity
Fundamental red flags (Piotroski 1/9)

Strengths

Low debt relative to equity
Strong returns on equity (25%)
Capital is working hard (ROCE 29%)
Revenue compounding 33% over 3 years

Risks

Fundamental red flags (Piotroski 1/9)

How we got there

Fair value methods

Residual income

25% ROE fading to 12% over ~10 yrs, on ₹21 book

₹37

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹40

Analyst target

No analyst coverage

—

Blended fair value₹38

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Strong returns on equity (25%)
Capital is working hard (ROCE 29%)
Revenue compounding 33% over 3 years
Profit growing 20% a year
Promoters hold a controlling stake

Bear case

Fundamental red flags (Piotroski 1/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

42.8Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

24.7%Strong

Above 15% is considered healthy for Indian equities

ROCE

29.0%Efficient

Above 18% means capital is working hard

Debt/Eq

0.16Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹1,034 Cr

P/B

5.62

EPS

₹3.36

Div Yield

—

What changed

Recent changes

Foreign investors-3.7% stake last quarter
Domestic institutions-0.4% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 42.8×

Growth

Strong

+33% rev CAGR

Profitability

Excellent

24.7% ROE

Financial health

Rock solid

D/E 0.16

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹589.97L Cr

Trades1,985

VWAP₹143.40

Face value₹5.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+33.2%

—

10Y

—

Profit

+19.7%

—

10Y

—

EPS

-70.9%

—

10Y

—

Profile

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 33.5%

Watch-outs

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Company has high debtors of 187 days.
Working capital days have increased from 39.9 days to 90.9 days

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Foreign investors sold 3.69 pts; domestic institutions reduced 0.41 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

71%

Promoter

Promoters

71.3%0.00

Public

23.5%+4.08

FII / FPI

3.0%-3.69

DII

2.2%-0.41

Quarterly trend

Ownership over time

Q1 FY27

Promoter71.29%

FII3.01%

DII2.22%

Public23.47%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.[1]